Medication info

Yuhan Simvastatin Tablet 20 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Brownish yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 200200478 · Notified 2002.11.08

This product's status changed to Approval withdrawn on 2025.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For the recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), refer to the information below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. This medicine may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not substantially excreted by the kidneys, no dosage adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose for each patient as appropriate according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease

  • Coronary artery disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • secondary hyperlipidemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medicine helps reduce the risk of cardiovascular disease. It lowers the risk of heart attacks and strokes in adults with a history of coronary artery disease, diabetes, peripheral vascular disease, or stroke, and reduces the risk of complications from coronary and other vascular procedures. It is also used to treat hyperlipidemia, lowering total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while raising HDL cholesterol. It is effective for patients with genetic dyslipidemia, such as familial hypercholesterolemia, and is also used in pediatric patients when diet alone is insufficient. This drug is widely used in the prevention of cardiovascular diseases and the improvement of dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For the recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), refer to the information below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. This medicine may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not substantially excreted by the kidneys, no dosage adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose for each patient as appropriate according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This drug is primarily used to lower blood cholesterol levels by acting in the liver to inhibit cholesterol synthesis. When taking this medication, muscle problems may occur; therefore, if symptoms like muscle pain or weakness appear, consult a doctor immediately. Particularly, the risk of myopathy and rhabdomyolysis increases when taking high doses (80mg), so caution is required at high doses. Patients with poor liver function or liver disease should not take this drug and should undergo regular liver function testing. Women who are pregnant or may become pregnant, or who are breastfeeding, should not take this drug and must discontinue it immediately if pregnancy is confirmed while being treated. This drug can interact with certain medications, so if you are taking other medicines, you must inform your doctor or pharmacist. Elderly individuals, patients with reduced kidney function, and those with hypothyroidism should be monitored more closely when taking this drug. During treatment, it is advisable to avoid certain foods like grapefruit juice, which can increase the blood concentration of this drug and raise the risk of side effects. This drug may slightly increase blood sugar levels, so patients at risk for diabetes should monitor their blood sugar regularly. In children and adolescents, this drug should not be used in those under 10 years old or in females before menarche, and adolescents aged 10 to 17 should take it under a doctor's guidance. Various side effects, such as liver function abnormalities, blood test abnormalities, allergic reactions, and skin rashes can occur during treatment, so if any abnormal symptoms arise, consult healthcare professionals immediately. In case of overdose, visit a medical facility immediately for appropriate treatment, and keep this drug out of the reach of children. If receiving treatment from another physician while taking this drug, you must inform them that you are taking it.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 87 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste distortion
  • ocular movement disorder
  • facial paresis
  • tremor
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataracts
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photophobia
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • erythema multiforme
  • sensory numbness in limbs
  • tingling sensation
  • cold sensation
  • thrombocytopenia
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is advisable to store it at room temperature between 1°C and 30°C, avoiding areas that are too hot or too cold. This helps maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Brownish yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.